Suppr超能文献

干扰素诱导的基孔肯雅病毒感染限制

Interferon-induced restriction of Chikungunya virus infection.

作者信息

Suzuki Youichi

机构信息

Department of Microbiology and Infection Control, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

出版信息

Antiviral Res. 2023 Feb;210:105487. doi: 10.1016/j.antiviral.2022.105487. Epub 2022 Dec 22.

Abstract

Chikungunya virus (CHIKV) is an enveloped RNA virus that causes Chikungunya fever (CHIKF), which is transmitted to humans through the bite of infected Aedes mosquitos. Although CHIKVF had been regarded as an endemic disease in limited regions of Africa and Asia, the recent global reemergence of CHIKV heightened awareness of this infectious disease, and CHIKV infection is currently considered an increasing threat to public health. However, no specific drug or licensed vaccine is available for CHIKV infection. As seen in other RNA virus infections, CHIKV triggers the interferon (IFN) response that plays a central role in host defense against pathogens. Experimental evidence has demonstrated that control of CHIVK replication by the IFN response is achieved by antiviral effector molecules called interferon-stimulated genes (ISGs), whose expressions are upregulated by IFN stimulation. This review details the molecular basis of the IFN-mediated suppression of CHIKV, particularly the ISGs restricting CHIKV replication.

摘要

基孔肯雅病毒(CHIKV)是一种包膜RNA病毒,可引起基孔肯雅热(CHIKF),该病毒通过受感染的伊蚊叮咬传播给人类。尽管基孔肯雅热在非洲和亚洲的有限地区一直被视为地方病,但最近基孔肯雅病毒在全球范围内的再次出现提高了人们对这种传染病的认识,目前基孔肯雅病毒感染被认为对公共卫生构成越来越大的威胁。然而,对于基孔肯雅病毒感染,尚无特效药物或获批的疫苗。正如在其他RNA病毒感染中所见,基孔肯雅病毒会触发干扰素(IFN)反应,该反应在宿主抵御病原体的防御中起核心作用。实验证据表明,干扰素反应对基孔肯雅病毒复制的控制是通过称为干扰素刺激基因(ISGs)的抗病毒效应分子实现的,这些分子的表达在干扰素刺激下上调。本综述详细阐述了干扰素介导的对基孔肯雅病毒抑制作用的分子基础,特别是限制基孔肯雅病毒复制的干扰素刺激基因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验